314 related articles for article (PubMed ID: 11002867)
1. Use of clotrimazole/betamethasone diproprionate by family physicians.
Shaffer MP; Feldman SR; Fleischer AB
Fam Med; 2000 Sep; 32(8):561-5. PubMed ID: 11002867
[TBL] [Abstract][Full Text] [Related]
2. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.
Fleischer AB; Feldman SR
Clin Ther; 1999 Oct; 21(10):1725-31. PubMed ID: 10566568
[TBL] [Abstract][Full Text] [Related]
3. Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians.
Balkrishnan R; Cook JM; Shaffer MP; Saltzberg FB; Feldman SR; Fleischer AB
Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):133-8. PubMed ID: 15072111
[TBL] [Abstract][Full Text] [Related]
4. Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency.
Railan D; Wilson JK; Feldman SR; Fleischer AB
Dermatol Online J; 2002 Oct; 8(2):3. PubMed ID: 12546758
[TBL] [Abstract][Full Text] [Related]
5. Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections.
Greenberg HL; Shwayder TA; Bieszk N; Fivenson DP
Pediatr Dermatol; 2002; 19(1):78-81. PubMed ID: 11860579
[TBL] [Abstract][Full Text] [Related]
6. Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994.
Smith ES; Fleischer AB; Feldman SR
J Am Acad Dermatol; 1998 Jul; 39(1):43-7. PubMed ID: 9674396
[TBL] [Abstract][Full Text] [Related]
7. Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents.
Alston SJ; Cohen BA; Braun M
Pediatrics; 2003 Jan; 111(1):201-3. PubMed ID: 12509578
[TBL] [Abstract][Full Text] [Related]
8. The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone.
Flint ND; Rhoads JLW; Carlisle R; Ferrel M; Hopkins ZH; Secrest AM
Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755955
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
[TBL] [Abstract][Full Text] [Related]
10. Candid-B cream in the treatment of candidiasis with inflammatory dermatoses--National Study Group.
Wadhwa SL; Thomas J; Ainapure SS; Desai A
J Indian Med Assoc; 2000 Sep; 98(9):580, 582. PubMed ID: 11291799
[TBL] [Abstract][Full Text] [Related]
11. Quality of dermatologic care delivered by physician assistants: an analysis of prescribing behavior for the combination antifungal agent clotrimazole-betamethasone.
Satyaprakash A; Balkrishnan R; Camacho FT; Jayawant SS; Fleischer AB; Feldman SR
Arch Dermatol; 2007 Dec; 143(12):1591-2. PubMed ID: 18087018
[No Abstract] [Full Text] [Related]
12. [Triderm in the treatment of atopic dermatitis].
Kaliuzhnaia DD
Voen Med Zh; 1999 Feb; 320(2):53-5. PubMed ID: 10330896
[No Abstract] [Full Text] [Related]
13. Combination dermatological products: a comparison of betamethasone dipropionate/clotrimazole/gentamicin sulphate and flumethasone pivalate/clioquinol creams.
Hojyo T
J Int Med Res; 1987; 15(5):255-63. PubMed ID: 2960577
[TBL] [Abstract][Full Text] [Related]
14. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
[TBL] [Abstract][Full Text] [Related]
15. Characterization of diaper dermatitis in the United States.
Ward DB; Fleischer AB; Feldman SR; Krowchuk DP
Arch Pediatr Adolesc Med; 2000 Sep; 154(9):943-6. PubMed ID: 10980800
[TBL] [Abstract][Full Text] [Related]
16. Dermatologic disease in family medicine.
Awadalla F; Rosenbaum DA; Camacho F; Fleischer AB; Feldman SR
Fam Med; 2008; 40(7):507-11. PubMed ID: 18928078
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
18. [Our experience using triderm for the treatment of external otitis].
Vakhrushev SG; Pronina IuV; Zyrianov MM; Bugakova TM
Vestn Otorinolaringol; 2004; (4):42-3. PubMed ID: 15496842
[No Abstract] [Full Text] [Related]
19. Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams.
Wheat CM; Bickley RJ; Hsueh YH; Cohen BA
J Pediatr; 2017 Jul; 186():192-195.e1. PubMed ID: 28438376
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.
Smith EB; Breneman DL; Griffith RF; Hebert AA; Hickman JG; Maloney JM; Millikan LE; Sulica VI; Dromgoole SH; Sefton J
J Am Acad Dermatol; 1992 Jan; 26(1):125-7. PubMed ID: 1732321
[No Abstract] [Full Text] [Related]
[Next] [New Search]
